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Abstract
Background: The objective of this study was to assess the compliance of health care workers
(HCWs) employed in Hajj in receiving the meningococcal, influenza, and hepatitis B vaccines.
Methods: A cross-sectional survey of doctors and nurses working in all Mena and Arafat hospitals
and primary health care centers who attended Hajj-medicine training programs immediately before
the beginning of Hajj of the lunar Islamic year 1423 (2003) using self-administered structured
questionnaire which included demographic data and data on vaccination history.
Results: A total of 392 HCWs were studied including 215 (54.8%) nurses and 177 (45.2%) doctors.
One hundred and sixty four (41.8%) HCWs were from Makkah and the rest were recruited from
other regions in Saudi Arabia. Three hundred and twenty three (82.4%) HCWs received the
quadrivalent (ACYW135) meningococcal meningitis vaccine with 271 (83.9%) HCWs receiving it
at least 2 weeks before coming to Hajj, whereas the remaining 52 (16.1%) HCWs received it within
< 2 weeks. Only 23 (5.9%) HCWs received the current year's influenza virus vaccine. Two hundred
and sixty (66.3%) of HCWs received the three-dose hepatitis B vaccine series, 19.3% received one
or two doses, and 14.3% did not receive any dose. There was no statistically significant difference
in compliance with the three vaccines between doctors and nurses.
Conclusion: The meningococcal and hepatitis B vaccination coverage level among HCWs in Hajj
was suboptimal and the influenza vaccination level was notably low. Strategies to improve
vaccination coverage among HCWs should be adopted by all health care facilities in Saudi Arabia.
Background
Ensuring that health care workers (HCWs) are immune to
vaccine-preventable diseases is an essential part of suc-
cessful employee health programs. Optimal use of vac-
cines can prevent transmission of vaccine-preventable
diseases and eliminate unnecessary work restriction. Pre-
vention of illness through comprehensive HCWs immu-
nization programs is far more cost-effective than case
management and outbreak control [1]. In Saudi Arabia,
the national vaccination recommendations for HCWs are
generally the same as those recommended by the Centers
for Disease Control and Prevention [2]. Meningococcal
vaccination of all HCWs is additionally recommended in
Saudi Arabia, particularly for those working directly with
pilgrims in Hajj. Influenza and hepatitis B vaccines are
also emphasized for this group of HCWs. These three and
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other required vaccines are made available free of charge
for all HCWs in all health care facilities in Saudi Arabia.
The objective of this study was to assess the compliance of
HCWs employed in Hajj in receiving the meningococcal,
influenza, and hepatitis B vaccines that are particularly
recommended for Hajj by the Ministry of Health.
Methods
Hajj
Hajj is the fifth of the five pillars of Islam. Any healthy
Muslim adult is required to perform Hajj once in his/her
life if he/she is financially and physically capable. The
Hajj begins on the 8th day of Dhul-Hijjah, the 12th month
of the lunar Islamic year, and ends on the 13th day of the
same month. Hajj has to be performed in three main loca-
tions in Makkah, namely, the sacred Kaaba (in the holy
city of Makkah), and Mena and Arafat, which are approx-
imately 5 and 18 Kilometers far from Makkah, respec-
tively. Approximately, 2–3 million pilgrims perform Hajj
every year; one third of whom come from within Saudi
Arabia and two thirds come from other countries. Most
pilgrims stay in fire-resistant air-conditioned camping
tents in Mena during the entire Hajj period. Financially
deprived pilgrims who cannot afford to pay for the cost of
staying in camps usually stay outdoor. Free medical care
services are provided to pilgrims by the Saudi Ministry of
Health.
Study design and population
A cross-sectional survey was conducted in Mena and Ara-
fat during the Hajj season of the Islamic year 1423 corre-
sponding to 2003 Gregorian. HCWs included in the study
were all doctors and nurses working in Mena and Arafat
hospitals and primary health care centers who attended
Hajj-medicine training programs immediately before the
beginning of Hajj. Many of the HCWs were recruited from
various regions in Saudi Arabia to supplement the local
HCWs working in Makkah to cover the extensive medical
services provided to pilgrims in Hajj.
Data collection
The Saudi Ministry of Health approved the study. Data
were collected using a structured questionnaire which
included demographic data and data on vaccination his-
tory. The questionnaire was anonymously self-adminis-
tered by HCWs with supervision from the research team
members.
Data analysis
Data entry and statistical analysis were performed using
computer and the Statistical Package for Social Science
(SPSS) program. Descriptive statistics, cross tabulations,
and Chi-square test were performed as appropriate. Mul-
tiple logistic regression analysis was performed to identify
predictors of compliance to vaccination after controlling
for possible confounding factors. Statistical significance
was set at < 0.05.
Results
A total of 392 HCWs attended the Hajj-medicine training
programs. All HCWs agreed to participate in the study
with 100% response rate. Two hundred and fifteen
(54.8%) HCWs were nurses and 177 (45.2%) HCWs were
doctors. Three hundred and fifteen (80.4%) HCWs
worked in hospitals, whereas 77 (19.6%) HCWs worked
in primary health care centers during this Hajj season. Of
the 392 HCWs, 164 (41.8%) HCWs were from Makkah,
85 (21.8%), from Riyadh, 53 (13.6%), from the Eastern
Region, 28 (7.3%), from Asir, 21 (5.3%), from Al-Qassim,
13 (3.4%), from Najran, 8 (1.9%), each from Al-Baha and
Jizan, and 4 (1.0%), each from Al-Jouf, Hail, and North-
ern Region.
Table 1 shows the socio-demographic characteristics of
HCWs included in the study. Of the 392 HCWs, 323
(82.4%) HCWs received the quadrivalent (ACYW135)
meningococcal vaccine recommended by the Ministry of
Health. There was no statistically significant difference in
compliance with this vaccine between doctors and nurses
(78.9% versus 85.4%, respectively, p = 0.172). Of the 323
(82.4%) HCWs who received the meningococcal vaccine,
271 (83.9%) HCWs received it at least 2 weeks and not
more than 3 years before coming to Hajj as recommended
by the Ministry of Health, whereas the remaining 52
(16.1%) HCWs received it within less than 2 weeks.
Only 23 (5.9%) HCWs received the current year's influ-
enza virus vaccine. There was no statistically significant
difference in compliance with this vaccine between doc-
tors and nurses (5.6 % versus 7.4 %, respectively, p =
0.573).
Of the 392 HCWs, 260 (66.3%) HCWs completed the
three-dose series of the hepatitis B vaccine, 48 (12.2%)
HCWs received 2 doses, 28 (7.1%) HCWs received one
dose, and 56 (14.3 %) HCWs did not receive any dose of
the vaccine. There was no statistically significant differ-
ence in compliance with hepatitis B vaccination between
doctors and nurses (Table 2). Of the 260 HCWs who com-
pleted the hepatitis B vaccination series, 134 (51.5%)
HCWs had post-vaccination tests to confirm development
of immunity.
Table 3 shows a bivariate analysis of the compliance of
392 health care workers for receiving the quadrivalent
meningococcal meningitis, influenza, and hepatitis B vac-
cines according to their gender, age group, nationality,
years of experience, degree, position, and original place of
work. This analysis showed no statistically significant dif-
ference in compliance with the receipt of the vaccinesBMC Infectious Diseases 2007, 7:80 http://www.biomedcentral.com/1471-2334/7/80
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Table 1: Socio-demographic characteristics of 177 doctors and 
215 nurses included in the study
Characteristic Number Percent
Sex:
Doctors:
Male 142 80.2
Female 35 19.8
Nurses:
Male 49 22.8
Female 166 77.2
Age group (year)
Doctors
20–30 7 4.0
31–40 71 40.1
41–50 79 44.6
51–60 20 11.3
Nurses
20–30 100 46.5
31–40 69 32.1
41–50 33 15.3
51–60 13 6.1
Nationality:
Doctors:
Saudi 46 26.0
Non-Saudi 131 74.0
Nurses:
Saudi 62 28.8
Non-Saudi 153 71.2
Years of experience
Doctors
1–10 68 38.4
11–20 85 48.0
21 or more 24 13.6
Nurses
1–10 115 53.5
11–20 78 36.3
21 or more 22 10.2
Degree:
Doctors:
Bachelor 52 29.4
Master/Diploma 72 40.7
Doctorate/Board 53 29.9
Nurses:
Diploma 137 63.7
Bachelor 78 36.3
Position
Doctors:
General Practitioner 30 16.9
Resident 57 32.2
Specialist 69 39.0
Consultant 21 11.9
Nurses
Staff nurse 192 89.3
Head nurse 23 10.7
Original work place
Makkah 164 41.8
Riyadh 85 21.8
North region 4 1.0
Eastern region 53 13.6
Jazan 8 1.9
Asir 28 7.3
Najran 13 3.4
Baha 8 1.9
Qaseem 21 5.3
Aljouf 4 1.0
Hail 4 1.0
among the various groups with two exceptions; the com-
pliance of non-Saudi HCWs for the receipt of the menin-
gitis vaccine was significantly higher than that of the Saudi
mates (84.2% versus 77.8%, p = 0.027), and the compli-
ance of HCWs with lower degrees (diploma and bachelor)
was significantly higher than that of HCWs with higher
degrees (p = 0.011). Multivariate logistic regression anal-
ysis confirmed that non-Saudi nationality was an inde-
pendent predictor of a better compliance with the
meningitis vaccine (odds ratio = 3.28, 95% confidence
interval = 1.17 – 9.21, p = 0.024). However, lower degrees
were not independent predictors of a better compliance
with this vaccine (p = 0.797).
Discussion
Until year 2000, bivalent (AC) meningococcal vaccina-
tion was recommended for all people coming to the Hajj
areas from inside or outside Saudi Arabia. Since 2000,
Neisseria meningitides W135 caused outbreaks among pil-
grims for the first time in history [3]. As a result, since year
2000, the quadrivalent (ACWY135) meningococcal vacci-
nation has been recommended by the Ministry of Health
for all people coming for Hajj with revaccination every 3
years if the unconjugated polysaccharide vaccine was
used. The quadrivalent meningococcal polysaccharide
vaccine has been made available free of charge in all
health care facilities for all HCWs as well as for other peo-
ple within Saudi Arabia intending to perform Hajj. This
study showed that compliance of HCWs with this vaccine
was suboptimal (82.4%) with almost one fifth of HCWs
being unvaccinated. Non-Saudi HCWs were significantly
more compliant with this vaccine than Saudi HCWs. Fur-
ther studies are needed to determine the reasons for the
lower compliance among the Saudi HCWs. Possible
explanations for this difference include better awareness
of the importance of this vaccine among the non-Saudis
and false sense of security and perceived low likelihood of
contracting meningococcal meningitis among Saudi
HCWs. Gender, age, years of experience, qualification
degree, position, and original place of work were not sig-
nificant predictors of compliance to the meningococcal
vaccine.
Table 2: Compliance of 392 health care workers (177 doctors and 
215 nurses) with the hepatitis B virus vaccination
Number of doses Overall % % of doctors % of nurses
None 14.3 14.4 14.1
1 dose 7.1 7.2 6.8
2 doses 12.2 16.2 9.2
3 or more doses 66.3 62.3 69.9
X2
df = 6 = 11.25, p-value = 0.081.BMC Infectious Diseases 2007, 7:80 http://www.biomedcentral.com/1471-2334/7/80
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Table 3: Bivariate analysis of the compliance of 392 health care workers (HCWs) for receiving the ACYW135 meningococcal 
meningitis, influenza, and at least one dose of the hepatitis B vaccines according to their gender, age group, nationality, years of 
experience, degree, position, and original place of work.
Number of 
HCWs
HCWs who received the 
meningococcal vaccine (%)
P HCWs who received the 
influenza vaccine (%)
P HCWs who received at 
least one dose of the 
hepatitis B vaccine (%)
P
Total number of 
HCWs
392 323 (82.4) 23 (5.9) 336 (85.7)
Sex
Male 191 150 (78.5) 0.327 9 (4.7) 0.319 157 (82.2) 0.567
Female 201 173 (86.1) 14 (7.0) 179 (89.1)
Age group 
(year)
20–30 107 92 (86.0) 0.972 5 (4.7) 0.683 95 (88.8) 0.156
31–40 140 113 (80.7) 8 (5.7) 125 (89.3)
41–50 112 93 (83.0) 6 (5.4) 88 (78.6)
51–60 33 25 (75.8) 4 (12.1) 28 (84.8)
Nationality
Saudi 108 84 (77.8) 0.027 7 (6.5) 0.680 90 (83.3) 0.104
Non-Saudi 284 239 (84.2) 16 (5.6) 246 (86.6)
Experience in 
year
1–10 183 154 (84.2) 0.903 8 (4.4) 0.108 164 (89.6) 0.149
11–20 163 133 (81.6) 14 (8.6) 132 (81.0)
21 or more 46 36 (78.3) 1 (2.2) 40 (87.0)
Degree
Diploma 137 111 (81.0) 0.011 8 (5.8) 0.204 110 (80.3) 0.088
Bachelor 130 116 (89.2) 8 (6.2) 117 (90.0)
Master/high 
diploma
72 60 (83.3) 2 (2.8) 60 (83.3)
Doctorate/
Board
53 36 (67.9) 5 (9.4) 49 (92.5)
Position
Consultant 21 16 (76.2) 0.500 3 (14.3) 0.351 19 (90.5) 0.810
Specialist 69 54 (78.3) 3 (4.3) 62 (89.9)
Resident 57 46 (80.7) 1 (1.8) 46 (80.7)
General 
practitioner
30 23 (76.7) 2 (6.7) 24 (80.0)
Head nurse 23 16 (69.6) 2 (8.7) 18 (78.3)
Nurse 192 168 (87.5) 12 (6.3) 167 (87.0)
Original work 
place
Makkah 164 136 (82.9) 0.574 12 (7.3) 0.651 136 (82.9) 0.643
Riyadh 85 75 (88.2) 2 (2.4) 73 (85.9)
North 
region
4 2 (50.0) 0 2 (50.0)
Eastern 
region
53 45 (84.9) 4 (7.5) 49 (92.5)
Jazan 8 6 (75.0) 0 8 (100.0)
Asir 28 21 (75.0) 1 (3.6) 24 (85.7)
Najran 13 12 (92.3) 2 (15.4) 13 (100.0)
Baha 8 8 (100.0) 0 4 (50.0)
Qaseem 21 14 (66.7) 2 (9.5) 19 (90.5)
Aljouf 4 2 (50.0) 0 4 (100.0)
Hail 4 2 (50.0) 0 4 (100.0)BMC Infectious Diseases 2007, 7:80 http://www.biomedcentral.com/1471-2334/7/80
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During community influenza outbreaks, admitting
patients infected with influenza to hospitals has led to
nosocomial transmission of the disease, including trans-
mission from staff to patients [4-6]. Transmission of influ-
enza among medical staff causes absenteeism and
considerable disruption of health care [7-10]. The Health-
care Infection Control Practices Advisory Committee
(HICPAC) and the Advisory Committee on Immuniza-
tion Practices (ACIP) in the United States recommend that
all HCWs be vaccinated annually against influenza [11].
However, in spite of a long-standing recommendation for
influenza vaccination of HCWs, and the availability of a
safe and effective vaccine, influenza vaccination coverage
levels among HCWs remain substantially low worldwide
[11]. For instance, during 1989–2003, HCWs influenza
vaccination coverage levels in the United States increased
from 10% to 40%; however, coverage levels have
remained relatively constant since 1997 [12]. Substan-
tially lower vaccination rates have been reported among
HCWs who have contact with certain populations at high
risk in the United States [13-16]. Low influenza vaccina-
tion coverage rates have also been reported from Europe
[17-20]. This vaccine is particularly recommended for
HCWs working in Hajj because of the very high risk of
acquiring influenza infection in such overcrowded situa-
tions. However, in this study, only 5.9% of HCWs
received the current year's influenza virus vaccine. Gender,
age, nationality, years of experience, qualification degree,
position, and original place of work were not significant
predictors of compliance to this vaccine. Reported barriers
to HCWs receipt or acceptance of influenza vaccination
include fear of vaccine side effects, insufficient time or
inconvenience, perceived ineffectiveness of the vaccine,
medical contraindication, perceived low likelihood of
contracting influenza, reliance on treatment with homeo-
pathic medications, avoidance of medications, and fear of
needles [11].
Hepatitis B virus (HBV) infection is a major infectious
hazard for HCWs [11,12]. In general, the seroprevalence
of HBV among HCWs is twofold to fourfold higher than
that of blood donor controls [23]. The risk for acquiring
HBV infection from occupational exposures is dependent
on the frequency of percutaneous and permucosal expo-
sures to blood or body fluids containing blood [22]. The
risk for transmission from a single needlestick varies
according to hepatitis B e antigen status: 1% to 6% for e
antigen-negative blood compared with 22% to 40% with
e antigen-positive blood [23]. Not all cases of HBV trans-
mission are explained by needlesticks, suggesting that
other modes of spread may be possible [23]. HBV vaccina-
tion of all HCWs has been strongly recommended [2]. The
HBV three-dose vaccine series is 88% effective [24,25].
From 1985 to 1994, the use of HBV vaccine and adher-
ence to other preventive measures such as standard pre-
cautions lead to a 90% decline of HBV infection among
HCWs in the United States [26,27]. Even though, HBV
vaccination of all HCWs has been strongly recommended,
the vaccination coverage level of HCWs remains subopti-
mal with many studies reporting rates between 40–86%
[28-35]. A recent study from Saudi Arabia reported an
overall compliance rate of 71.6% (932/1302) among
HCWs [36]. In that study the compliance rate was 79.5%
(492/619) among nurses, 78.3% (242/309) among tech-
nicians, and 52.9% (198/374) among physicians [36]. In
the current study, the compliance rate was similar to ear-
lier reports as only 66.3% of HCWs received the three-
dose vaccine series, 19.3% received one or two doses, and
14.3% did not receive any dose. Gender, age, nationality,
years of experience, qualification degree, position, and
original place of work were not significant predictors of
compliance to this vaccine.
Several strategies for improving HCWs vaccination cover-
age have been recommended [11]. Successful HCWs vac-
cination programs are multifaceted and combine
publicity and education to combat fears and misconcep-
tions about vaccines, use of reminder recall systems,
efforts to remove administrative and financial barriers,
role modeling, and monitoring and feedback on vaccina-
tion coverage [11]. Educational programs should empha-
size the benefits of HCWs vaccination for staff and
patients [11]. Organized campaigns that promote and
make vaccine accessible can improve vaccination rates
among HCWs [11]. Vaccination of senior medical staff or
opinion leaders has been associated with higher vaccina-
tion acceptance among staff members under their leader-
ship [11]. Removing administrative barriers such as costs
and providing vaccine in locations and at times easily
accessible by HCWs can substantially improve vaccine
acceptance[11]. Making vaccine readily accessible at con-
gregate areas (e.g., clinics), during conferences, or by use
of mobile carts has been demonstrated to improve vacci-
nation coverage rates [11]. Monitoring vaccination cover-
age by facility area (e.g., ward or unit) or occupational
group allows facilities to identify where vaccination levels
are low and interventions that should be targeted. Obtain-
ing declination statements from HCWs who refuse vacci-
nation for reasons other than medical contraindications
can assist facilities in identifying personnel who might
require targeted education or other interventions to over-
come barriers to vaccine acceptance. In addition, collec-
tion of such information will allow health-care facilities to
determine what proportion of their staff are reached and
offered vaccine [11].
Conclusion
The meningococcal and hepatitis B vaccination coverage
level among HCWs in Hajj was suboptimal and the influ-
enza vaccination rate was notably low. RecommendedBMC Infectious Diseases 2007, 7:80 http://www.biomedcentral.com/1471-2334/7/80
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strategies to improve vaccination coverage among HCWs
should be adopted by all health care facilities in Saudi
Arabia to ensure adequate vaccination coverage particu-
larly with the Hajj-related vaccines.
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